Novavax files for U.S. authorization of COVID-19 vaccine

(Reuters) – Novavax Inc said on Monday it had submitted an application to the U.S. Food and Drugs Administration for an emergency use authorization for its COVID-19 vaccine.

(Reporting by Leroy Leo)